MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus Inc., a pioneer in cloud-based genome informatics and data management, today announced that Intermountain Cancer Genomics is now using DNAnexus as the underlying bioinformatics platform for the center’s personalized treatment options for cancer patients.
Intermountain Cancer Genomics is the in-house genomics laboratory of Intermountain Healthcare, an internationally recognized not-for-profit system of 22 hospitals and medical groups with more than 185 physician clinics in Utah and southeastern Idaho. Through collecting and analyzing patient DNA and identifying mutations to determine why and how cancer tumors are growing, physicians select genetically targeted therapies to treat cancer patients. Intermountain has begun treating cancer with this innovative genomic sequencing platform approach.
The DNAnexus platform enables Intermountain Cancer Genomics to run its bioinformatics pipeline in the cloud, providing unmatched computational power, cost, scalability and access to genetic testing and data. DNAnexus worked with Intermountain to develop their cloud-based bioinformatics pipeline; one that translates raw data into interpretable variants. With DNAnexus, Intermountain can scale up quickly and is able to share its cancer testing tools and datasets securely outside of its healthcare group, offering a network of cancer resources to physicians and patients everywhere while advancing genomic discoveries.
“We selected DNAnexus because of the company’s leading bioinformatics and cloud computing expertise, combined with the best-in-class security and compliance standards of the platform,” said Lincoln Nadauld, Medical Director of Intermountain Cancer Genomics. “The underlying infrastructure that DNAnexus provides allows us to focus on our core competencies of R&D and patient care while revolutionizing cancer treatments.”
“Intermountain Cancer Genomics is a perfect example of how DNAnexus helps healthcare providers accelerate medical discovery through the sharing and management of genomic data,” said Richard Daly, CEO, DNAnexus. “DNAnexus is proud to provide the network for genomic medicine to advance the future of cancer research and treatment with Intermountain.”
DNAnexus provides a global network for sharing and managing genomic data and tools to accelerate genomic medicine. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. The DNAnexus team is made up of experts in computational biology and cloud computing who work with organizations to tackle some of the most exciting opportunities in human health, making it easier—and in many cases feasible—to work with genomic data. With DNAnexus, organizations can stay a step ahead in leveraging genomics to achieve their goals. The future of human health is in genomics. DNAnexus brings it all together. For more information please visit: https://dnanexus.com or follow us on Twitter @dnanexus